Salubris (Suzhou) Pharmaceuticals Co., Ltd.
Wholly-owned by Shenzhen Salubris Pharmaceuticals Co., Ltd., it has been mainly engaged in the research, development, production and sales of Biologics, and established Suzhou Engineering Technology Research Center for Recombinant Protein Medicine including recombinant proteins, monoclonal antibodies and so on involved in fields of osteoporosis, anti-tumor, diabetes, heart diseases and other diseases. The production platform established in accordance with the requirements of Chinese GMP and EU GMP standards has prokaryotic production lines and eukaryotic production lines. The eukaryotic production lines are the most advanced intelligent 2000L Flexfactory production platform in China, which can be used for clinical production and commercial production of extracellular expression products such as CHO cells.
More